Private Advisor »

Esperion Therapeutics shares owned by Private Advisor

Quarter-by-quarter ownership of Esperion Therapeutics (ESPR) shares owned by Private Advisor from 13F filings

Historical chart of Private Advisor investment in Esperion Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Esperion Therapeutics held by Private Advisor consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Esperion Therapeutics by Private Advisor

Quarter filed Position value Share count Share price at filing
2023-12-31 $86k 29k 2.99
2023-09-30 $28k 29k 0.98
2023-06-30 $40k 29k 1.39
2020-06-30 $60k 1.2k 51.24

More positions owned by Private Advisor

Apple (AAPL)
Vanguard Index Fds Total Stk Mkt (VTI)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Spdr Ser Tr Portfolio S&p500 (SPLG)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Microsoft Corporation (MSFT)
Spdr Ser Tr Portfoli S&p1500 (SPTM)
Spdr Ser Tr Prtflo S&p500 Gw (SPYG)
Ishares Tr Core S&p500 Etf (IVV)
Amazon (AMZN)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Select Sector Spdr Tr Technology (XLK)
Vanguard Index Fds Growth Etf (VUG)
Vanguard Index Fds Value Etf (VTV)
Spdr Ser Tr Portfolio Agrgte (SPAB)

View all positions for Private Advisor

Top funds holding Esperion Therapeutics

Daniel D. Thurber
Vanguard Group
Bellevue Group
Meditor
Millennium Management
Two Sigma Investments
Two Sigma Advisers
Jpmorgan Chase & Co
Tang Capital Management
D. E. Shaw & Co
Walleye Trading
GSA Capital Partners
Schonfeld Strategic Advisors
Jacobs Levy Equity Management
Goldman Sachs Group

View all funds holding Esperion Therapeutics